A potent cytidine deaminase biodegrader as pan-cancer cells sensitiser to deoxycytidine analogue-based chemotherapies

Nicolas Béry(John Radcliffe Hospital), Pierre CORDELIER(Inserm)

Research Square

March 4, 2026

10.21203/rs.3.rs-7179653/v1

Cited by 0

Related Papers

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS

|Nature Communications|2020|128

A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2

|Science Advances|2021|17

Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders

|iScience|2024|7